Body weight and leptin plasma levels during treatment with antipsychotic drugs

American Journal of Psychiatry

Volumn 156, Issue 2, 1999, Pages 312-314

  Kraus, Thomas ^b   Haack, Monika ^b   Schuld, Andreas ^b   Hinze Selch, Dunja ^b   Kühn, Martin ^b   Uhr, Manfred ^b   Pollmächer, Thomas ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL; LEPTIN; NEUROLEPTIC AGENT; OLANZAPINE;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCHIZOPHRENIA;

ADIPOSE TISSUE; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BODY MASS INDEX; BODY WEIGHT; CLOZAPINE; HALOPERIDOL; HOSPITALIZATION; HUMANS; LEPTIN; MENTAL DISORDERS; PIRENZEPINE; PROTEINS; WEIGHT GAIN;

EID: 0032983548     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bustillo JR, Buchanan RW, Irish D, Breier A: Differential effect of clozapine on weight: a controlled study. Am J Psychiatry 1996; 153:817-819
2. Beasley CM Jr, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S: Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 1996; 14:111-123
3. Brömel T, Blum WF, Ziegler A, Schulz E, Bender M, Fleischhaker C, Remschmidt H, Krieg J-C, Hebebrand J: Serum leptin levels increase rapidly after initiation of clozapine treatment. Mol Psychiatry 1998; 3:76-80
4. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-548
5. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, Orahilly S: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387:903-908
6. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269:543-546
7. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269:540-543
8. Hebebrand J, Blum WF, Barth N, Coners H, Englaro P, Juul A, Ziegler A, Warnke A, Rascher W, Remschmidt H: Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol Psychiatry 1997; 2:330-334
9. Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS: Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 1997; 138:3859-3863
10. Jalenques I, Tauveron I, Albuisson E, Audy V, Fleury-Duhamel N, Codert AJ: Weight gain as a predictor of long term clozapine efficiency. Clin Drug Invest 1996; 12:16-25